Apollo Medical Holdings Reports Third Quarter Fiscal Year 2015 Financial Results

Revenue of $7.6 million, a 170% Year-Over-Year Increase

GLENDALE, Calif., Feb. 25, 2015 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated physician-centric healthcare delivery company announced its fiscal 2015 third quarter results for the three months ended December 31, 2014.

Financial Highlights for the Three Months Ended December 31, 2014 Compared to the Three Months Ended December 31, 2013:

Net revenue of $7.6 million, an increase of 170% from $2.8 million in the comparable period of 2013, attributable to the continued growth of Maverick Medical Group and recent acquisitions
Loss from operations of $1.5 million compared to a loss of $808,596 in the comparable quarter of 2013, attributable to increased legal and professional fees related to acquisitions as well as increased infrastructure costs related to ApolloMed ACO and Maverick Medical Group
On December 31, 2014, the Company had total assets of $15.0 million
On December 31, 2014, the Company had cash and cash equivalents of $7.0 million

"This was another quarter of significant year-over-year revenue growth for ApolloMed," stated Warren Hosseinion, M.D., CEO of Apollo Medical Holdings. "The healthcare industry is rapidly shifting to a risk-based, accountable model, a model which we have been executing on for several years. We believe that ApolloMed is well-positioned to capitalize on the opportunities that will result from the changing healthcare landscape."

For more details on ApolloMed's fiscal year 2015 third quarter results, please refer to the Company's 10-Q filed with the U.S. Securities Exchange Commission and accessible at www.sec.gov.

UNAUDITED FINANCIAL TABLES TO FOLLOW:

APOLLO MEDICAL HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

ASSETS
	December 31,		March 31,
	2014		2014
CURRENT ASSETS
Cash and cash equivalents	$	6,951,763	$	6,831,478
Restricted cash		40,000		20,000
Accounts receivable, net		3,506,674		1,508,461
Other receivables		12,431		-
Due from affiliates		11,457		24,041
Prepaid expenses		135,983		42,200
Total current assets		10,658,308		8,426,180

Deferred financing costs, net		294,326		366,286
Property and equipment, net		560,938		94,948
Intangible assets, net		1,911,832		59,627
Goodwill		1,386,480		494,700
Other assets		211,088		41,636
TOTAL ASSETS	$	15,022,972	$	9,483,377

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
Accounts payable and accrued liabilities	$	2,562,008	$	1,447,040
Medical liabilities		1,805,554		552,561
Note and line of credit payable, net of discount, current portion		1,584,764		444,764
Holdback consideration		376,236		-
Total current liabilities		6,328,562		2,444,365

Notes payable, net of discount, non-current portion		5,038,041		5,344,565
Convertible notes payable, net of discount		2,002,307		962,978
Warrant liability		2,452,201		2,354,624
Conversion feature liability		487,630		-
Deferred tax liability		185,972		-
Total liabilities		16,494,713		11,106,532

COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (NOTES 10 and 11 )

STOCKHOLDERS' DEFICIT
Preferred stock, par value $0.001;
5,000,000 shares authorized; none issued		-		-
Common Stock, par value $0.001; 100,000,000 shares authorized,
48,634,549 and 49,134,549 shares issued and outstanding
as of December 31, 2014 and March 31, 2014, respectively		48,635		49,135
Additional paid-in-capital		16,338,075		15,083,365
Accumulated deficit		(18,340,602)		(16,347,588)
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.		(1,953,892)		(1,215,088)
Non-controlling interest		482,151		(408,067)
Total stockholders' deficit		(1,471,741)		(1,623,155)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	15,022,972	$	9,483,377

APOLLO MEDICAL HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)

	Three months ended December 31,				Nine months ended December 31,
	2014		2013		2014		2013

Net revenues	$	7,642,474	$	2,834,161	$	23,402,254	$	7,970,276

Costs and expenses
Cost of services		6,090,345		2,032,851		15,511,829		6,748,726
General and administrative		2,889,598		1,603,625		8,350,837		4,569,020
Depreciation and amortization		194,060		6,281		399,240		19,164
Total costs and expenses		9,174,003		3,642,757		24,261,906		11,336,910

Loss from operations		(1,531,529)		(808,596)		(859,652)		(3,366,634)

Other (expense) income
Interest expense		(362,935)		(156,257)		(969,060)		(518,509)
Change in fair value of warrant and conversion feature liability		358,433		-		480,568		-
Other		112,648		(739)		51,736		6,751
Total other income (expense)		108,146		(156,996)		(436,756)		(511,758)

Loss before provision for income taxes		(1,423,383)		(965,592)		(1,296,408)		(3,878,392)

(Benefit) provision for income taxes		(31,944)		(800)		66,647		-

Net loss		(1,391,439)		(964,792)		(1,363,055)		(3,878,392)

Net income attributable to noncontrolling interest		(300,144)		-		(629,959)		-

Net loss attributable to Apollo Medical Holdings, Inc.	$	(1,691,583)	$	(964,792)	$	(1,993,014)	$	(3,878,392)
Other comprehensive loss:
Unrealized change in value of marketable securities		(33,088)		-		-		-
Comprehensive loss	$	(1,724,671)	$	(964,792)	$	(1,993,014)	$	(3,878,392)

NET LOSS PER SHARE:
BASIC AND DILUTED	$	(0.03)	$	(0.02)	$	(0.04)	$	(0.10)

WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING:
BASIC AND DILUTED		48,759,549		39,038,732		49,009,094		37,251,775

About Apollo Medical Holdings, Inc. (ApolloMed)

Headquartered in Glendale, California and dedicated to putting the 'Patient First,' ApolloMed is a leading provider of physician-centric integrated healthcare management services, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in California, Mississippi and Ohio. ApolloMed is addressing the healthcare needs of the nation's largest population center by leveraging its integrated healthcare delivery platform comprised of three affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association), AKM Medical Group (IPA), Apollo Palliative Services and ApolloMed Care Clinics. This platform combines hospitalist medicine, critical care medicine, case management and transition management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. ApolloMed strives to improve medical outcomes with high quality, cost efficient care. For more information, please visit www.apollomed.net.

Forward Looking Statements

This press release may contain forward-looking statements, including information about management's view of Apollo Medical Holdings, Inc. ("the Company") future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. Some factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2014, under the caption "Risk Factors", which is on file with the Securities and Exchange Commission and available in the "Investor" section of the Company's website under the heading "SEC Filings". The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Apollo Medical Holdings, Inc.

For More Information, PLEASE CONTACT:

Dave Gentry
RedChip Companies Inc.
1-800-733-2447
dave@redchip.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/apollo-medical-holdings-reports-third-quarter-fiscal-year-2015-financial-results-300041094.html

SOURCE Apollo Medical Holdings, Inc.

Released February 25, 2015